Effect of rifampicin on the pharmacokinetics and pharmacodynamics of glimepiride

per Niemi, Mikko, Kivistö, Kari T, Backman, Janne T, Neuvonen, Pertti J
Publicat 2000

In vitro evaluation of valproic acid as an inhibitor of human cytochrome P450 isoforms: preferential inhibition of cytochrome P450 2C9 (CYP2C9)

per Wen, Xia, Wang, Jun-Sheng, Kivistö, Kari T, Neuvonen, Pertti J, Backman, Janne T
Publicat 2001

Fexofenadine pharmacokinetics are associated with a polymorphism of the SLCO1B1 gene (encoding OATP1B1)

per Niemi, Mikko, Kivistö, Kari T, Hofmann, Ute, Schwab, Matthias, Eichelbaum, Michel, Fromm, Martin F
Publicat 2005

Effect of an oral contraceptive preparation containing ethinylestradiol and gestodene on CYP3A4 activity as measured by midazolam 1′-hydroxylation

per Palovaara, Sanna, Kivistö, Kari T, Tapanainen, Pasi, Manninen, Pekka, Neuvonen, Pertti J, Laine, Kari
Publicat 2000

Expression of CYP3A4, CYP3A5 and CYP3A7 in human duodenal tissue

per KIVISTÖ, KARI T., BOOKJANS, GERHARD, FROMM, MARTIN F., GRIESE, ERNST-ULRICH, MÜNZEL, PETER, KROEMER, HEYO K.
Publicat 1996

Pharmacokinetics and response to pravastatin in paediatric patients with familial hypercholesterolaemia and in paediatric cardiac transplant recipients in relation to polymorphisms...

per Hedman, Mia, Antikainen, Marjatta, Holmberg, Christer, Neuvonen, Mikko, Eichelbaum, Michel, Kivistö, Kari T, Neuvonen, Pertti J, Niemi, Mikko
Publicat 2006

Stereoselective pharmacokinetics of cisapride in healthy volunteers and the effect of repeated administration of grapefruit juice

per Desta, Zeruesenay, Kivistö, Kari T, Lilja, Jari J, Backman, Janne T, Soukhova, Nadia, Neuvonen, Pertti J, Flockhart, David A
Publicat 2001